What should be the primary target of "treat to target" in psoriatic arthritis?

What should be the primary target of "treat to target" in psoriatic arthritis?

<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...

Detaylı Bibliyografya
Asıl Yazarlar:	Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Journal of Rheumatology 2018

Benzer Materyaller

What should be the primary target of ‘treat to target’ in PsA?
Yazar:: Coates, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
Yazar:: Coates, L, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
Yazar:: Coates, L, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Sustained very low disease activity and remission in psoriatic arthritis patients
Yazar:: Lubrano, E, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

New approved drugs for psoriatic arthritis
Yazar:: F.M. Perrotta, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)

Precision medicine in psoriatic arthritis: how should we select targeted therapies?
Yazar:: Al-Mossawi, H, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
Yazar:: Ennio Lubrano, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

How should we define disease and outcomes in axial psoriatic arthritis?
Yazar:: Coates, LC
Baskı/Yayın Bilgisi: (2021)

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Yazar:: Ennio Lubrano, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
Yazar:: P.S. Helliwell
Baskı/Yayın Bilgisi: (2011-09-01)

The dynamics of response as measured by multiple composite outcome tools in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial.
Yazar:: Coates, L, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Does treat to target or achieving remission improve radiographic outcome in psa?
Yazar:: Coates, L, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores
Yazar:: Weinstein, SM, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Mixed methods study of clinicians’ perspectives on barriers to implementation of treat to target in psoriatic arthritis
Yazar:: Dures, E, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Novel concepts in psoriatic arthritis management: Can we treat to target?
Yazar:: Tucker, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Comparing the visual analogue scale and the numerical rating scale in patient-reported outcomes in psoriatic arthritis
Yazar:: Ye, W, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
Yazar:: Gladman, DD, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study
Yazar:: Helliwell, PS, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Assessment of patient-physician interactions in psoriatic arthritis: national results of the ASSIST Study
Yazar:: Perrotta, FM, ve diğerleri
Baskı/Yayın Bilgisi: (2024)

Measuring physical function in psoriatic arthritis: comparing the Multi-Dimensional Health Assessment Questionnaire to the Health Assessment Questionnaire Disability Index
Yazar:: Ye, W, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Occult axial involvement in patients with psoriatic arthritis mutilans: a case report
Yazar:: F.M. Perrotta, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Current concepts and unmet needs in psoriatic arthritis
Yazar:: Mahmood, F, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Psoriatic arthritis: prospects for the future
Yazar:: Hackett, S, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Should methotrexate have any place in the treatment of psoriatic arthritis?
Yazar:: Ye, W, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
Yazar:: Helliwell, PS, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Yazar:: Coates, L, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Measuring outcomes in psoriatic arthritis
Yazar:: Ogdie, A, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Outcome measures in psoriatic arthritis: where next?
Yazar:: Hackett, S, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
Yazar:: Ennio Lubrano, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Assessing disease activity in psoriatic arthritis: a literature review
Yazar:: Tucker, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Psoriatic arthritis: lessons from imaging studies and implications for therapy
Yazar:: Mathew, A, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Treatment to target in psoriatic arthritis with apremilast: probability of achieving targets and comprehensive control of disease manifestations
Yazar:: Mease, PJ, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial
Yazar:: Helliwell, P, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Cost-effectiveness of tight control of inflammation in early psoriatic arthritis: economic analysis of a multicenter randomized controlled trial
Yazar:: O'Dwyer, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Identification of psoriatic arthritis in patients with psoriasis
Yazar:: Coates, LC, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
Yazar:: Soriano, ER, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Remission in psoriatic arthritis—where are we now?
Yazar:: Coates, L, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

Psoriatic arthritis: imaging techniques
Yazar:: E. Lubrano, ve diğerleri
Baskı/Yayın Bilgisi: (2012-06-01)

Validation of new potential targets for remission and low disease activity in psoriatic arthritis in patients treated with golimumab
Yazar:: Coates, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Psoriatic arthritis
Yazar:: FitzGerald, O, ve diğerleri
Baskı/Yayın Bilgisi: (2021)